Monthly Archives: June 2011

EMA Introduces Laser Treatment of Nail Fungus

Medical devices maker Cutera Inc has obtained the 510 (k) clearance from the U.S. Food and Drug Administration (“FDA”) for its GenesisPlus laser for treating onychomycosis (nail fungus).

Onychomycosis, a fungal infection of the toenails or fingernails, afflicts roughly 35 million Americans. The condition represents clinical symptoms such as discoloration/ thickening of the nail and separation of the nail plate from the nail bed. It is more likely to develop in people with conditions such as diabetes, psoriasis, and peripheral arterial disease (“PAD”). The worldwide market for onychomycosis therapies is estimated to be more than $2 billion.

Roughly 20% of the people affected with onychomycosis seek treatment annually in the U.S. Despite its wide prevalence, there are limited approved treatments for this condition. Currently, widely used prescription therapies are topical and oral drugs.

However, these treatments have limited clinical success rates due to prolonged and inconvenient treatment regimens and side-effects including potential liver toxicity. Moreover, topical drugs generally have poor efficacy. An innovative non-invasive approach for treating onychomycosis is the application of laser energy to the nail plate with an “Nd:YAG” laser such as the GenesisPlus.

The GenesisPlus laser represents a major advancement in the treatment of onychomycosis. It leverages Cutera’s proprietary microsecond technology and delivery system to improve patient experience. The device has a larger laser spot (compared with fiber lasers) which enables fast treatment and uniform coverage. With the approval of GenesisPlus, patients now have a fast and effective therapy option for onychomycosis without the risks of adverse side-effects


Denervating Agent: BOTOX
It’s important to know the difference between Botox and fillers (Botox stops the muscle contractions; fillers plump up the furrows), but it’s even more important to emphasize that in trained hands, Botox does not paralyze muscles. Rather, it is used in an artistic fashion to restore a more youthful appearance to the face.

A relatively painless procedure, Botox injections are virtually downtime free. Muscle actions play a big role in aging around the eyes, as contractions lead to initial dynamic wrinkles followed by more permanent lines; Botox is great for stopping crow’s-feet and the vertical frown lines between the brows, and it prevents the muscle movement that leads to fine lines and furrows. The treatment can also be used as an “injectable browlift,” to slightly elevate the brow and eliminate horizontal lines across the forehead to help the upper face look younger and more relaxed. Many plastic surgeons consider Botox to be an integral part of a surgical browlift, since its use before surgery can help relax the muscles and facilitate healing.

Just like injectable fillers, a topical anesthetic may be applied to make treatment more comfortable. Then, over a short period of time (roughly 10 minutes, depending on how many areas are being treated), your doctor will strategically place several injections. You may be red or bruised at the injection sites for up to a few days, and in rare instances, patients will report mild flu-like symptoms after treatment. Results become visible in three to seven days, and last for three to four months. Botox is not a permanent solution—you’ll need repeat treatments every three to four months. Your doctor may choose to use the treatment in conjunction with a filler to provide the best results.